NAPQI adducts in patients with selective hypersensitivity to acetaminophen

Puntos clave

• Acetaminophen hypersensitivity relates closely to NAPQI adduct generation and detoxification impairment.
• GSTM1 gene variability appears to influence individual risk for acetaminophen hypersensitivity.
• The analysis explores biomarkers as critical in predicting acetaminophen sensitivity among patients.
• Findings highlight the need for deeper investigation into NAPQI adducts and their role in hypersensitivity.

Resumen